REYATAZ atazanavir (as sulfate) 300mg capsule bottle

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cf13d8014f9dbf6d
Product Name: REYATAZ atazanavir (as sulfate) 300mg capsule bottle
Artg Id: 134967
Artg Name: REYATAZ atazanavir (as sulfate) 300mg capsule bottle
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2007-08-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2a574ec5d2e0c3e2bb4015686a19398e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/975facaff3deb868a23757ab28497445.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cf13d8014f9dbf6d

Type

Standard